Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Parenthetical) (Details)

v3.22.4
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Parenthetical) (Details) - shares
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Anti-dilutive securities      
Warrants issued to purchase common stock   211,709 211,709
Private Placement - December 2020      
Anti-dilutive securities      
Warrants issued to purchase common stock 282,809 282,813 282,813
Private Placement September2022      
Anti-dilutive securities      
Warrants issued to purchase common stock 13,813,912    
Tyme Merger      
Anti-dilutive securities      
Warrants issued to purchase common stock 41,085    
First Draw of Loan Agreement      
Anti-dilutive securities      
Warrants issued to purchase common stock 2,754   2,755
Second Draw on Loan Agreement      
Anti-dilutive securities      
Warrants issued to purchase common stock 1,738   1,739